CFO Sauvage Philippe bought 7,300 shares in 2 transactions for $13,215.50; holdings +280.6%. Cluster buy signal with 4 other insiders in past 14 days.
Sauvage Philippe, Chief Financial Officer of Nuvation Bio, purchased 7,300 shares across 2 separate transactions on 2025-06-16 and 2025-06-17 at a blended average price of $1.81, increasing his holdings from 2,602 to 9,902 shares (a +280.6% increase). This filing is part of a cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated interest at current valuation levels despite the company reporting negative net income of $-53,236,000.00 in its most recent period and a market cap of $609,070,727.04. The stock has declined -53.3% from its 52-week high of $3.83 and -22.2% over the past 30 days, meaning these purchases occurred during a period of significant price erosion. This multi-insider buying activity against deteriorating fundamentals and falling price momentum warrants examination into whether management sees near-term catalysts or believes current levels represent structural opportunity.